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Summary 
An inhibitory signal is delivered to natural killer (NK) 
cells and a subset of cytotoxic 1 cells upon recognition 
of HLA class I molecules on target cells. We demon- 
strate that soluble forms of killer cell inhibitory recep- 
tors(KIR) bind directly and specifically to HLA-Calleles 
on transfected cells. Furthermore, transfer of Individ- 
ual KIR into NK clones reconstituted recognition of 
HLA-C on target cells, leading to inhibition of lysis. 
Using such functional reconstitution, a related KIR that 
confers specificity for some HLA-B alleles was also 
identified. These KIR share consewed tyrosine phos- 
phorylation motifs in their cytoplasmic tells. Thus, a 
single receptor in NK cells provides both specificity 
for HLA class I on target cells and the inhibitory signal 
that prevents lysis. 
introduction 
Natural killer (NK) cells kill virus-infected cells (Biron et 
al., 1989; Malnati et al., 1993; Brutkiewicz and Welsh, 
1995) and contribute to the rejection of bone marrow allo- 
or xenografts (Vu et al., 1992; Murphy et al., 1993). They 
also play an important regulatory role in immune re- 
sponses to parasites and bacteria (Scott and Trinchieri, 
1995). Despite their lack of immunoglobulin and T cell 
antigen receptors (TCR), NK cells display specificity in 
target cell recognition. In contrast with T cells, the specific- 
ity of target cell recognition by NK cells is not provided by 
triggering receptors but by inhibitory receptors associated 
with recognition of major histocompatibility complex 
(MHC) class I molecules (Yokoyama, 1995; Lanier and 
Phillips, 1995; Leibson, 1995; Raulet and Held, 1995). The 
importance of peptides bound to class I molecules for 
proper recognition by NK ceils suggests that the same 
type of stably assembled class I complex of heavy chain, 
82-microglobulin, and peptide is recognized by NK and T 
cells (Correa and Raulet, 1995; Malnati et al., 1995). Tar- 
get cells that fail to express MHC class I molecules, or 
properly assembled MHC class I molecules, are generally 
lysed by NK cells (Storkus et al., 1989; Ljunggren et al., 
1989; Ljunggren and KBrre, 1990; Liao et al., 1991). Thus, 
the outcome of MHC class I recognition is totally different 
for cytotoxic T cells and NK cells. Whereas class l-restricted 
CD8+ T cells are triggered to kill target cells that express 
a given class I molecule, NK cells receive a negative signal 
upon recognition of class I molecules that overrides trig- 
gering signals for lysis (Karlhofer et al., 1992; Moretta et 
al., 1993; Correa et al., 1994; Vitale et al., 1995; Kaufman 
et al., 1995). 
A family of molecules, called Ly49, expressed on mouse 
NK cells, provides specificity for MHC class I molecules 
on target cells (Karlhofer et al., 1992; Mason et al., 1995; 
Stoneman et al., 1995). These receptors are disulfide- 
linked homodimers belonging to the C-type lectin type II 
transmembrane protein superfamily (Yokoyama and Sea- 
man, 1993). Ly49 molecules bind to class I molecules 
(Kane, 1994; Daniels et al., 1994a) and this binding re- 
quires the carbohydrate structure of class I molecules 
(Daniels et al., 1994b). In surprising contrast, a family of 
human NK receptors called p58 (Moretta et al., 1993) is 
composed of type I transmembrane proteins with two im- 
munoglobulin-related extracellular domains (Wagtmann 
et al., 1995; Colonna and Samaridis, 1995). Antibody- 
blocking experiments have implicated ~58 receptors in the 
recognition of H&C alleles (Moretta et al., 1993; Ciccone 
et al., 1994; Vitale et al., 1995). Cross-linking of these 
receptors delivers negative signals to killer ceils that inhib- 
its target cell lysis. Specificity of NK clones for HLA-Cw3 
and related alleles (Colonna et al., 1993) correlated with 
surface expression of one member of the p58 NK receptor 
family, whereas other NK clones specific for HtA-Cw4 and 
related alleles express a different p58 receptor, as defined 
with monoclonal antibodies (MAbs) (Moretta et al., 1993; 
Ciccone et al., 1994; Vitale et al., 1995). 
The family of ~58 receptors displays sequence diversity 
in both the extracellular and intracellular domains (Wagt- 
mann et al., 1995). Three different lengths of cytoplasmic 
tails were observed, even among p58 receptors that were 
closely related in their extracellular immunoglobulin do- 
mains. These data suggested that p58 receptors may dif- 
fer both in their ligand specificities and in their signaling 
capabilities. The five different p58 members identified in a 
single individual exceed the minimal number of receptors 
needed to distinguish between the two groups of HLA-C 
alleles. Analysis of the expression of these receptors in 
NK cells by SSCP revealed a complex distribution, with 
individual NK clones expressing always at least one, and 
often more, receptors (Wagtmann et al., 1995). 
Other inhibitory receptors have been described that cor- 
relate with specificity for HLA-B molecules (Litwin et al., 
1994; Moretta et al., 1994). In particular, a molecule of 
70 kDa called NKBl is expressed on NK clones that are 
specific for HLA-6 alleles belonging to the Bw4 subgroup 
(Gumperz et al., 1995). The recent isolation of a cDNA 
clone encoding NKBl revealed that this molecule contains 
three immunoglobulin domains, two of which are related 
to p58 @‘Andrea et al., 1995). Additional receptors for 
HLA-B must exist, as some NK clones that do not express 
NKBl can also recognize alleles of the Bw4 group (Litwin 
et al., 1994; Gumperz et al., 1995; Lanier et al., 1995). 
A regulatory role for p58 and NKBl receptors in T cell 
responses has been suggested by their presence on a 
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subset of T cells (Ferrini et al., 1994; Mingari et al., 1995; 
Phillips et al., 1995). Cross-linking of these receptors on 
T cells, either with MAbs or by interaction with target cells, 
resulted in inhibition of activation signals delivered by 
the TCR. 
The identification of the ~58 family of receptors raises 
several interesting questions. Are ~58 molecules specific 
receptors for MHC class I molecules or are they only sig- 
naling molecules? Which type of cytoplasmic tail among 
those found in ~58 receptors is responsible for the inhibi- 
tory function? Does the p58familyinclude inhibitory recep- 
tors involved in the recognition of molecules other than 
H&C? 
The existence of completely different receptors, such 
as Ly49 in mouse and ~58 in humans, with apparently 
similar function, is surprising. To date, mouse homologs 
of ~58 and human homologs of Ly49 receptors have not 
been isolated. Are ~58 and Ly49 independent receptors 
with overlapping function, or do they function as corecep- 
tors, with one providing specificity for MHC class I, the 
other providing signaling capability? Binding studies are 
required to determine whether the ~58 receptors them- 
selves provide specificity in NK recognition of HLA-C al- 
leles. 
Here, we provide answers to these questions. Specific 
recognition of HLA-C alleles by ~58 receptors was demon- 
strated by direct binding with soluble recombinant ~58 
molecules. Second, a functional reconstitution system de- 
veloped in human NK clones revealed that a single ~58 
molecule can confer specificity for an HLA-C allele and 
that receptors with the longer form of cytoplasmic tail con- 
taining tyrosine phosphorylation motifs can deliver the 
negativesignal. Finally, ap58-related molecule with asimi- 
lar cytoplasmic tail was identified that inhibited NK clones 
upon specific recognition of HLA-B molecules. 
Results 
Soluble ~58 Receptors Bind Specifically 
to HLA-C Alleles 
Studies on HLA-C allorecognition by NK cells indicated 
the existence of two main groups of NK clones (Moretta 
et al., 1993; Colonna et al., 1993; Vitale et al., 1995). One 
group of clones, which is inhibited by HLA-Cw3 and related 
alleles, including HlA-Cwl, HLA-Cw7, and HLA-Cw8, ex- 
presses ~58 molecules reactive with the MAb GL183. An- 
other group of clones that is inhibited by HLA-Cw4 and 
related alleles (HLA-Cw2, HLA-Cw5, and HLA-Cw6) ex- 
presses ~58 molecules reactive with MAb EB6. To test 
whether these correlations reflect direct binding of ~58 
receptors to HLA-C alleles, soluble receptors were pro- 
duced as p58-lg fusion proteins. cDNA fragments encod- 
ing the entire extracellular part of p58-cl6 (reactive with 
MAb GL163) or p58-cl42 (reactive with MAb EB6) were 
cloned upstream of sequences encoding the hinge, CH2, 
and CH3 domains of human immunoglobulin Gl (IgGl) 
to produce soluble divalent receptors (Aruffo et al., 1990). 
Vectors encoding only the hinge CH2 and CH3 of IgGl 
as controls or the p56-lg fusion proteins cl6-lg or cl42- 




Figure 1. Production of Soluble p58-lg Fusion Proteins 
Reducing SDS-PAGE analysis of soluble p!iS-lg molecules purified 
from supematants of transfected COS7 cells. Cells were mock- 
transfected (lane 1). transfecled with control vector encoding the Fc 
portion of human IgGl (lane 2), or with vectors encoding the cl6-lg 
(lane 3) or cl42-lg (lane 4) p5S-lg fusion proteins. The position of size 
markers in kilodaltons is indicated on the left. 
bolically labeled transfectants were tested for the pres- 
ence of the recombinant proteins by binding to protein 
A-sepharose followed by SDS-PAGE. In each case, pro- 
teins of the expected size (35 kDa for the control molecule 
and 75 kDa for p58-lg) were secreted into the medium 
(Figure 1). 
Purified soluble fusion proteins were tested for binding 
to the human B cell line 721.221, which lacks HLA-A, 
HLA-B, and H&C molecules, and to 721.221 cells 
transfected with the class I alleles HLA-Cw3, HLA-Cw4, 
or HLA-B27 (Figure 2). The soluble cl6-lg molecule bound 
specifically to HLA-Cw3 transfectants, whereas the cl42- 
lg molecule bound specifically to HLA-Cw4 transfectants. 
Neither molecule bound to 721.221 or to .221-827 cells, 
and the control molecule did not bind to any of the four 
cell lines. These data indicate that p58-cl6 encodes a NK 
receptor for HLA-Cw3 and p58-cl42 encodes a receptor 
for HLA-Cw4. Titrations of the recombinant soluble mole- 
cules between 3 pglml and 100 @ml revealed dose- 
dependent binding of p58-lg to cells expressing HLA-Cw3 
or HLA-Cw4 (data not shown). These results suggest 
that the ~58 NK receptors bind directly to HLA-C and dem- 
onstrate that discrimination between HLA-C alleles is 
achieved at the level of specific binding. 
NK Clones Maintain their Target Cell Specificity 
after Infection with Vacclnla Virus 
The existence of ~58 molecules with very similar extracel- 
lular domains but different types of cytoplasmic tails sug- 
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Figure 2. Soluble p58-lg Fusion Proteins Bind Specifically to Distinct 
HLA-C Alleles 
The human B cell line 721.221 (.221) and transfected 721.221 cells 
expressing HLACw3 (.221Cw3), HLACw4 (.221Cw4), or HtA-627 
(.221-827) were incubated with 10 @ml of purified Fc portion of hu- 
man IgGl (control), the cl-6 (cklg) or the cl-42 (cl42-lg) p68-lg fusion 
proteins, or with MAb F41326 (specific for HLA-C and some HLA-B 
alleles), as indicated. The cells were washed, incubated with FITC- 
conjugated goat anti-human immunoglobulin (top three panels) or anti- 
mouse immunoglobulin (bottom panel) antisera, and analyzed by flow 
cytometry. 
gested that receptors with similar ligand specificity may 
have different signaling capability. Therefore, it was im- 
portant to test which members of the ~58 family can medi- 
ate inhibition of target cell lysis. The most direct approach 
was to express functionally these receptors in NK cells. 
The large number of cells and the time required to obtain 
stable transfectants precluded the useof NK clones, which 
can only be established as short-term cultures. In the face 
of such limitations, and in view of the ability of a cytotoxic 
T cell line to retain lytic activity after infection with recombi- 
nant vaccinia viruses (Romeo and Seed, 1991) we ex- 
plored the use of the recombinant vaccinia virus expres- 
sion system to deliver individual receptor molecules into 
NK clones. 
Three important requirements must be fulfilled to 
achieve functional reconstitution of inhibition of NK lysis 
after vaccinia virus infection. First, NK cells should retain 
cytotoxicity towards unprotected target cells. Second, in- 
fection should not interfere with the negative signaling ma- 
chinery. Third, homogenous infection of NK cells is critical 
because the lytic activity of even a small fraction of unin- 
fected cells could obscure inhibitory effects in the infected 
cells. Conditions were developed to obtain homogenous 
infections of small numbers of NK clones (less than 1Og). 
The effect of vaccinia virus infection on NK-mediated lysis 
was examined using NK clones specific for HLA-Cw8, an 
allele related to HLA-Cw3 (Colonna et al., 1993). These 
NK clones kill the human 6 cell line 721.221, but do not 
lyse the same line stably transfected with HLA-Cw8 (.221- 





Figure 3. NK Clones Infected with Vaccinia Virus Retain their Lytic 
Capacity and MHC Class I Specificity 
(A) NK clone SR70, either uninfected (left) or infected with 30 pfukell 
of a recombinant vaccinia virus encoding the influenza virus haemag- 
glutinin H3 (Vat-HS), was tested for surface expression of H3 with 
anti-H3 MAbs followed by FITC goat anti-mouse IgG, and analyzed 
by flow cytometry. The histograms show relative log fluorescence of 
ungated cells. 
(6) The uninfected (left) or Vat-HB-infected (right) NK cells shown in 
(A) were tested for their ability to lyse 721.221 (.221) or 721.221 stably 
transfected with HLA-Cw6 (.221Cw8) in a 2 hr Wr release assay. The 
data shown were obtained at an effector to target ratio of 5; similar 
results were obtained at a ratio of 1. Similar results were obtained in 
several other experiments with the same and with three other NK 
clones. 
nant vaccinia virus encoding the influenza virus haemag- 
glutinin H3 molecule (Vat-H3) and simultaneously tested 
for surface expression of the H3 molecule and for cytolytic 
activity (Figure 3). The majority of the cells were produc- 
tively infected and expressed high levels of H3 at their 
surface after 1.5 hr of infection (Figure 3A). Longer infec- 
tions resulted in higher levels of surface H3 but diminished 
the lytic capacity of the infected cells (data not shown). 
Infection with Vat-H3 did not change the surface expres- 
sion of endogenous p58 molecules (data not shown). Vi- 
rus-infected NK cells were still able to kill unprotected 
721.221 cells, although at a somewhat reduced level. Im- 
portantly, they could still receive inhibitory signals from 
protected targets, as they did not kill .221Cw8 cells (Fig- 
ure 3B). The killing by virus-infected cells was usually at 
least 50% of that by uninfected cells. To correct for this 
reduction in killing, lysis mediated by vaccinia virus- 
infected NK clones was always compared with that of cells 
infected with control viruses. In all the experiments de- 
scribed here, Vat-H3 was used as control virus. 
These results indicated that although vaccinia virus in- 
fection causes a partial reduction in the lytic capacity of 
NK clones, it does not abrogate their ability to recognize 
class I or to receive inhibitory signals, suggesting that vac- 
cinia-mediated gene transfer could be used to test the 
function of individual receptor molecules in NK cells. 
Recombinant Vaccinia Viruses Encoding p58 
and Related Molecules 
To establish directly the role of p58 molecules in recogni- 
tion of HLA-C by NK cells, recombinant vaccinia viruses 
encoding two of the p58 receptors (encoded by cl-8 and 
~1-42) were constructed. We also generated recombinant 
viruses encoding two molecules, cl-5 and cl-l 1, that are 
structurally related to p58 but contain an additional immu- 
noglobulin-related domain (Figure 4A). Several cDNA 
clones encoding this type of molecule were isolated by 
hybridization during screening of a cDNA library with a 
p58 probe (Wagtmann et al., 1995) and sequenced com- 
pletely. Two of these three-domain molecules, cl-2 and 
cl-l 1, encode molecules with only4 aa differences in their 
extracellular domains. The third, ~1-5, differs from cl-l 1 by 
61 aa scattered throughout the entire length of the mole- 
cule; 45 of these differences occur in the extracellular do- 
mains. The second and third immunoglobulin domains of 
the three-domain molecules are about 74% and 85% iden- 
tical to the corresponding domains in p56 receptors. Dur- 
ing revision of this manuscript, a cDNA clone for NKBl 
was reported @‘Andrea et al., 1995); its deduced amino 
acid sequence is identical to that of ~1-2. Similar cDNA 
clones have been isolated by PCR amplification, including 
one, NKAT3 (Colonna and Samaridis, 1995) whose trans- 
lation is identical to that of cl-l 1. The expression in NK 
clones of the mRNA encoding these three-domain mole- 
cules was evaluated with an SSCP assay similar to that 
previously described for p58 molecules (Wagtmann et al., 
1995). Out of 35 NK clones that expressed at least one 
p56 molecule, 30 also expressed one or two three-domain 
molecules (data not shown). 
The three-domain molecules have cytoplasmic tails of 
either 64 or 95 aa, which are very similar to the longer 
type of cytoplasmic tails found in the p58 receptors. The 
functional relationship of the three-domain molecules to 
p56 was not known, but conservation of known tyrosine- 
based signaling motifs in the cytoplasmic tails of each 
type of receptor (Wagtmann et al., 1995; Colonna and 
Samaridis, 1995; D’Andrea et al., 1995) suggested they 
may have similar signaling capacity. 
To verify expression from the recombinant vaccinia vi- 
ruses encoding p58 or three-domain molecules, human 
B cells were infected and metabolically labeled with 
[?S]methionine. lmmunoprecipitation with specific anti- 
bodies revealed proteins with the expected size for mole- 
cules bearing core N-linked glycosylation (Figure 48). The 
expected molecular mass of the p56 molecule encoded 
by ~58-1~16, including four N-linked glycosylations, is 47.5 
kDa. It is 60 kDa for the one encoded by ~1-5. 
Transfer of a Single p58 Receptor into NK Clones 
Confers Specificity for HLA-C 
To examine the role of individual p58 receptors in target 
cell recognition by NK clones and to identify the cyto- 
plasmic tail involved in the delivery of a negative signal, 
two NKclones that did not recognize HLACw3, HLACw4, 
or HLACw8 were selected. Such clones lyse the HLA-A-, 
HLA-B-, and HLA-C-negative 721.221 cells, 721.221 cells 
A 
ss TM CM 
P58 SE,, , ,- 224 m/e4 
s-s s-s 
ss TM 0-r 
3D 
s-s s--s s-s 
B 
Ab:I GL183 1 Cyt42 1 CytS 1 Cytll 
Vat: 1 6 42 16 42 1 5 11 6 1 5 11 6 
Figure 4. Expression of ~59 and Related NK Receptors in Cells In- 
fected with Recombinant Vaccinia Viruses 
(A) Schematic diagram of the primary structure of ~58 NK receptors 
and of related moleculeswith three immunoglobulin domains(3D). The 
signal sequence and transmembrane region are shaded and hatched, 
respectively. The cytoplasmic tails of the molecules encoded by ~5% 
cl6 and ~59~142 are 75 and 94 aa, respectively, and those of the 
three-domain molecules cl-5 and cl-l 1 are 94 and 95 aa. Noncoding 
sequences are depicted as a thin line. 
(8) The B cell line 721.45 was infected with the indicated recombinant 
vacciniavirusesand labeled with [%]methionine. Cells(4 x lv were 
infected with 30 pfu/cell and pulse-labeled for 30 min (four lanes on 
the left) or with 20 pfu/cell and pulsed for 15 min (six lanes to the 
right). The infected cells were lysed in detergent and subjected to 
immunoprecipitation with the MAb GL193, or with rabbit antisera to 
the cytoplasmic tails of p59-cl42, CM, or cl-l 1, as indicated. Immuno- 
precipitates were analyzed by SDS-PAGE. The position of markers 
(in kilodaltons) is indicated on the left. 
transfected with HLA-Cw3, HLACw4, and HlACw8, as 
well as Cl R cells that express HLA-Cw4 as the only sero- 
logically detectable class I molecule (Zemmour et al., 
1992). The level of specific lysis of each of these targets 
by an individual NK clone may vary (data not shown). This 
small variability could complicate interpretation of the ef- 
fects of vaccinia-mediated p56 expression. For this rea- 
son, and to control for the nonspecific reductions in overall 
NK lysis due to vaccinia infection (see Figure 3), we always 
compared the lysis of a target by an NK clone infected 
with vaccinia encoding p58 to the lysis of that target by 
the same clone infected with Vat-H3. 
After infection of the two NK clones SR46 and SR50 with 
Vat-H3, Vat-6, or Vat-42, both clones expressed uniform 
surface levels of the relevant molecules (Figure 5A). Ex- 
pression of surface p58 appeared to be higher in clones 
infected with Vat-6 than with Vac42. NK clones infected 
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Figure 5. Expression of p56-cl42 in NK Clones Confers Specificity 
for HLA-Cw4 and p56-cl6 Confers Specificity for HLACw6 and HLA- 
Cw3 on Target Cells 
(A) Flow cytometry analysis of cell surface H3 and ~56 molecules in 
NK clone SR46 either uninfected or infected with Vat-H3. Vat-42, 
or Vat-6, as indicated. The cells were stained with isotype-matched 
anti-H3 MAbs or the anti-p56 MAbs ES6 or GL163 (all IgGl), followed 
by FITC goat anti-mouse IgG. The histograms show log fluorescence 
of ungated cells. Essentially identical results were obtained with NK 
clone SR 50. 
(8) Aliquots of the same infected SR46 (left) and SR50 (right) NK cells 
shown in (A) were tested for their ability to lyse 721.221, .221Cw6, 
and CIR cells in a 3 hr Yr release assay. Data are expressed as 
lysis by cells infected with Vacd (shaded) or Vat-42 (hatched) relative 
to lysis of the same targets by cells infected with Vat-H3. The specific 
lysis of 721.221, .221Cw6, and Cl R cells by Vat-HSinfected SR46 
cells was 39%. 14%b, and 47%, respectively, and for SR50 it was 62%, 
19%. and 541, respectively. Lysis is shown for an effector to target 
ratio of 9; similar data were obtained at a ratio of 3. Virtually identical 
results were obtained in a separate experiment with the same two NK 
clones. 
(C) NK clone SR50 infected with Vat-H3 (circles) or Vat-6 (squares) 
with any of the three viruses lysed the 721.221 target cells 
(Figure 58). In contrast, the .221-Cw8 targets were lysed 
by Vat-H3- and Vac42-infected NK clones but not by the 
Vat-8-infected NKclones (Figure 58). Infection with Vat-8 
also resulted in the inability to lyse .221-Cw3 targets (Fig- 
ure 5C). Reciprocally, the CwCpositive ClR cells were 
lysed by both Vat-HS and Vat-8-infected NK clones, but 
to a much lesser extent byVac-42-infected NK clones (Fig- 
ure 58). To confirm that Vat-42 conferred specificity for 
HLACw4, rather than some other ligand on ClR, we 
tested the ability of Vac4Pinfected cells to lyse .221 or 
221Cw4 cells. Infection with Vat-42 resulted in complete 
inhibition of lysis of .221-Cw4, whereas .221 cells were 
still lysed (Figure 5C). 
Thus, in agreement with the binding data, expression 
of p5Ecl42 in NK clones was sufficient to confer specificity 
for HlACw4, while expression of p58-cl8conferred speci- 
ficity for HLACw8 and HLACw3. Furthermore, the nega- 
tive signal delivered to the NK cells by these receptors 
identified them as killer cell inhibitory receptors (KIR; this 
name takes into account the existence of ~58 inhibitory 
receptors on both T cells and NK cells). Both p58-cl42 and 
p58-cl8 have the longer form of cytoplasmic tail containing 
tyrosine-phosphorylation motifs, demonstrating that this 
type of cytoplasmic tail can deliver the negative signal 
leading to inhibition of target cell lysis. 
ldentlflcatlon of an Inhibitory Receptor that 
Recognizes HLA-B27 and HLA-051 
To test whether the three domain molecules encoded by 
cl-5 and cl-l 1 were also inhibitory receptors that provide 
specificity for HLA molecules on target cells, NK clones 
infected with Vat-5 or Vat-1 1 were assayed on a panel 
of target cells, including Cl R (Cw4) and 721.45 (HLAA2, 
HLA-BS, HLA-Cwl). Lysis of 721.45 and Cl R cells by an 
NK clone was maintained after infection with Vat-H3 or 
Vacd (Figure 8A). In contrast, infection with Vat-1 1 did 
not affect lysis of ClR but completely blocked lysis of 
721.45 cells. Given that recognition of HLA-Cwl is ex- 
pected to involve one of the ~58 receptors (Ciccone et al., 
1992; Colonna et al., 1993), and that HLA-A2 is generally 
a poor protective allele (Storkus et al., 1991; Litwin et al., 
1993), the HLA-B5 molecule on 721.45 was a good candi- 
date for a protective element. 
To examine this possibility, the same NK clone was 
tested after infection for its ability to lyse Cl R cells or Cl R 
transfected with HLA-B27 or HLA-B51 (a 85 allele). Both 
827 and 851 belong to the Bw4 group of class I alleles. 
Whereas NK cells infected with Vacd lysed all three tar- 
gets as efficiently as cells infected with Vat-H3, infection 
with Vat-1 1 strongly inhibited lysis of Cl R-B27 and Cl R- 
851 targets, but not the lysis of ClR (Figure 8B). This 
inhibition of lysis of Cl R-B27 mediated by cl-l 1 was further 
confirmed in two additional NK clones. Transfer of cl-l 1 
into these NK clones inhibited their ability to lyse targets 
was tested for its ability to lyse .221 or .221Cw3 cells (left). NK clone 
SR50 infected with Vat-H3 (circles) or Vac42 (triangles) was tested 





























Figure 6. Expression of the Three-Domain Receptor Encoded by cl-l 1 
in NK Clones Confers Specificity for HLA-651 and HLA-627 on Target 
Cells 
(A) The NK clone SR50 was infected with Vat-H3, Vat-5, or Vat-1 1 
and tested for its ability to kill 721.45 (HLAA2. HLA-85. HLA-Cwl) 
and Cl R cells in a 3 hr Wr release assay. Data represent lysis by 
cells infected with Vat-5 (hatched) or Vat-1 1 (shaded) relative to the 
lysis by cells infected with Vat-HI. The specific lysis by the Vat-Hb 
infected ceils was 15% and 45% with 721.45 and C 1 R cells, respec- 
tively. Data shown were obtained at an effector to target ratio of 8; 
similar data were obtained at a ratio of 4. Virtually identical results 
were obtained in a separate experiment. 
(B) NK clone SR50 was infected as above and tested for its ability to 
lyse ClR cells and ClR transfected with HLA-627 or HLA-651 in a 4 
hr slCr release assay. Data shown represent lysis by cells infected 
with Vat-5 (hatched) or Vat-1 1 (shaded) relative to the lysis by cells 
infected with Vat-H3 (43%. 16%. and 45% specific lysis against Cl R, 
Cl R-B27. and Cl R-651). Data shown were obtained at an effector to 
target ratio of 9: similar data were obtained at a ratio of 3. Similar 
results were obtained in a separate experiment. 
(C) NK clone 5wA-05 was infected with Vat-H3 (circles) or Vat-11 
(squares) as described above and tested for its ability to lyse Cl R and 
Cl R-B27 targets in a 4 hr 5’Cr-reIease assay. Data are presented as 
specific lysis. Similar results were obtained in another experiment with 
the same and with another NK clone. 
bearing HLA-627, while infection with control Vat-H3 had 
little effect on the efficiency of lysis. Data from one such 
clone is depicted in Figure 6C. Thus, the receptor with 
three immunoglobulin domains encoded by cl-l 1 is a KIR 
specific for H LA-B27 and H LA-B51 . 
Discussion 
This study demonstrates direct binding of the KIR ~58 to 
HLA-C molecules expressed on transfected cells. Specific 
binding was revealed in that two different recombinant 
soluble ~58 receptors discriminated between two distinct 
HLA-C alleles. In addition, an expression system to evalu- 
ate ~58 function was established in NK clones and was 
used to demonstrate that several receptors of the p58 fam- 
ily with a conserved cytoplasmic tail provided the inhibitory 
signal upon recognition of specific HLA class I molecules. 
This system was exploited to identify a receptor with speci- 
ficity for HLA-B alleles, and provides a new tool for the 
molecular analysis of KIR. 
A New Receptor for YHC Class I 
Antibody-blocking experiments, as well as correlations be- 
tween NK cell phenotype and specificity for target cells, 
previously showed that ~58 receptors were associated 
with recognition of HLA-C on target cells (Ciccone el al., 
1992; Moretta et al., 1993; Vitale el al., 1995). These exper- 
iments indicated that ~58 was involved in target cell recog- 
nition in one of two ways. First, ~58 itself could carryspeci- 
ficity for class I molecules. Alternatively, ~58 could serve 
as a coreceptor or a signaling module associated with 
other receptors that provide class I specificity. The experi- 
ments described here demonstrate that p58 is a specific 
receptor for MHC class I on target cells. Studies with solu- 
ble class I molecules are required to establish whether 
HLA-C alone is sufficient for p58 binding. 
The direct binding of ~58 receptors to specific HIA-C 
molecules is incompatible with p58 serving as coreceptor 
for another class l-specific receptor such as Ly49. There- 
fore, coexpression of these two types of receptors in NK 
cells may represent a redundancy in NK inhibitory recogni- 
tion systems, possibly serving to ensure that every NK cell 
will express at least one inhibitory receptor. Even though 
both types of receptors may exist in each species, or at 
least in their common ancestor, humans and mice may 
have adapted to the predominant use of only one type of 
receptor. There is precedence for such adaptation in MHC 
class II molecules. Whereas the evolutionary counterparts 
of the human MHC class II isotypes HLA-DR and HLA-DQ 
are I-E and I-A in mice, respectively, human HLA-DR and 
mouse I-A molecules, which are not structural counter- 
parts, clearly predominate as restricting elements in cellu- 
lar immune responses. Similarly, mice may use predomi- 
nantly C-type lectin receptors to inhibit NK cells, whereas 
humans use immunoglobulin-related receptors for that 
function. The alternative scenario that they provide redun- 
dant systems for the inhibition of NK cells would be more 
effective if separate sets of NK cells expressed either p58 
or a Ly49 counterpart. 
Killer Cell Inhibitory Receptors Specific for HLA Class I 
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inhibition of NK Ceils Mediated by KIR 
An expression system in NK clones was successfully de- 
veloped to demonstrate that a single receptor confers both 
specific recognition of MHC class I on target ceils and 
the ability to inhibit NK-mediated iysis. The HLA-C allele 
specificities of ~58 receptors transferred into NK clones 
matched those determined bythe binding of soluble recep- 
tors Thus, the HIA-Cw4 specificity was transferred to NK 
clones by expression of p58-ci42, while the HIA-Cw8 and 
HLACw3 specificity was conferred by expression of p58- 
~18. This system was further exploited to determine the 
function and the specificity of a p58reiated molecule with 
three immunogiobuiin domains. The receptor encoded by 
cDNA cl-11 conferred specificity for HLA-627 and HLA- 
951 to NK clones. 
The functional reconstitution system is particularly use- 
ful because the multiplicity of ~58 and related NK recep- 
tors, and their complex pattern of expression in NK clones, 
precludes the assignment of their specificities based sim- 
ply on their endogenous expression in given NK clones. 
Specificities of NK clones did not correlate with expression 
of the molecule NKAT3 (Coionna and Samaridis, 1995) 
which is identical to that encoded by cl-l 1. In our own 
analysis of 18 NK clones that were inhibited by HLA-627, 
using an SSCP assay that distinguishes expression of cl-5 
from cl-2 and cl-l 1 (but not cl-2 and cl-l 1 from each other; 
data not shown), eight expressed cl-2/ci-11, two expressed 
~1-5, and six expressed one of each. Therefore, a receptor 
distinct from that encoded by cl-2 and cl-l 1 must also pro- 
vide specificity for HLA-B27. Our data are consistent with 
the description of HLA-B27-specific NK clones that do not 
express NKBl (Litwin et al., 1994; Gumperz et al., 1995) 
a receptor molecule identical to the one encoded by ~1-2. 
The expression system described here can now be used 
to determine the specificities of different members of the 
~58 family and those of other inhibitory receptors. 
The three KIR identified here share the same type of 
cytopiasmic tail with conserved YxxL motifs, which is dis- 
tinct from a shorter type carried by other members of the 
~58 family (Wagtmann et al., 1995). The longer cyto- 
piasmic tails include a motif related to the immune receptor 
tyrosine-based activation motif (ITAM) found in antigen 
receptors of B, T, and mast ceils (Weiss and Littman, 
1994). In contrast to TCR, FcR, and immunogiobuiin, 
where ITAM motifs are located on specialized signaling 
poiypeptides noncovaientiy associated with the antigen 
receptors, KIR have the potential to initiate the signal 
themselves through tyrosine phosphoryiation of their YxxL 
motifs and recruitment of proteins with SH2 domains. The 
identification of a common cytopiasmic tail involved in de- 
livery of the inhibitory signal for NK ceils and the develop 
ment of a functional expression system in NK ceils opens 
the way to a molecular dissection of this signaling pathway. 
Expdmental Procedures 
Cello and Antlbodies 
NK clones were generated and maintained as described (Matnati et 
al., 1993). The BEBV cell line 721.45 has been described (Kavathas 
et al., 1980). Hmy2CiR (ClR), a human B cell line expressing HLA- 
Cw4 as the only serologically detectable class I molecule (Zemmour 
et al., 1992), and CIR transfected with HLA-B’S101 were provided 
by W. E. Biddison (National Institute of Neurological Disorders and 
Stroke, National Institutes of Heafth). ClR transfected with HLA- 
6’2705 (Calvo et at., 1990) was a gift from J. Lopez de Caatro(Univer- 
shy of Madrid, Spain). The HLA-A-, HtA-5, and HlA-C-negative mu- 
tant 5EBV cell 721.221 (Shimizu and DeMars, 1989) and 721.221 
transfer&d with H LACw3, HfA-Cw4, or HLA-B’2705 were a gift from 
J. Gumperz and P. Parham (Stanford University). 721.221 transfected 
with HLACw8 was obtained from R. Biaseoni (National Cancer Insti- 
tute, Genova, Italy). Anti-H3 MAbs were a gift from R. Webster (St. 
Judes Children’s Hospital, Memphis, Tennessee). The MAb F41326 
with specificity for HLA-C and some HLA-Balkles(Mizuno et al., 1989) 
was a gift from S. Y. Yang (Memorial Sloan-Kettering Cancer Center, 
New York, New York). The anti-p58 MAbs GL183 and EB8 (Moretta 
et al., 1990) were provided by A. Moretta (National Cancer Institute, 
Genova, Italy). Rabbit antisera to the carboxy-end of the cytoplasmic 
tails of p58-cl42 (Cyt42), cl-5 (Cyt5). or cl-l 1 (Cytl 1) were raised by 
immunization with the synthetic peptides AESRSKVVSCP (Cyt42), 
PRAPQSGLEGVF (Cyt5). and AKPRSKWSCP (Cytll). Each antise- 
rum was affinity purified on the peptide used for immunization (Re- 
search Genetics). 
p58-Ig Fusion Proteins 
The sequences encoding the extracellular portions of p58-cl6 and 
p88-cl42 (Wagtmann et al., 1995) were amplified by polymerase chain 
reaction (PCR) with the forward primer 5’- CAG GGG GCG CTA GCG 
CAT GAG GGA GTA CAC AGA AAA CC - 3’ corresponding to se- 
quences immediately downstream of the signal sequence cleavage 
site and containing a Nhel site, and the backward primer 5’- GAG GTC 
CCA GGA TCC GCA TGA TGC AGO TGT CTG GGG l-TA CC - 3’ 
immediately upstream of the transmembrane region and containing 
a BamHl site. The amplification products were digested with Nhel and 
BamHl and cloned into the Nhel-BamHI cut Cdllnegl expression 
vector (a gift of B. Seed; see Aruffo et al., ISSO) in frame with the 
leader peptide of CD5 and the artificial splice site allowing fusion of 
the ~58 cDNA to genomic DNA encoding the hinge, CH2. and CH3 
regions of human IgGl (Aruffo et al., 1990). The last 3 aa of ~58 were 
HLH and the first 3 aa encoded by the vector were DPE, in the single 
letter code. COS7 cells were transfected using DEAE-Dextran. On 
day 4 after transfection, cells were labeled with Tmns-label (ICN Bio- 
medicals, Incorporated) (150 t&i/ml) for 4 hr and the supernatants 
were assayed for the presence of human immunoglobulinoontaining 
proteins by precipitation with protein A-sepharose. For large-scale 
production of fusion proteins, serum-free COS cell supernatants were 
collected on days 4 and 8 after transfectton and affinity purified on 
protein ASepharose as described (Ltnsley et al., 1991). The integrity 
of the purified proteins was verified by SDS-PAGE and Coomassie 
staining. Protein concentrations were determined with the Micro bicin- 
choninic acid assay (Pierce). 
Dlrecl BIndIng Aaaay 
The human B cell line 721.221 and transfected 721.221 cells express- 
ing HLACw3, HLACw4, or HLA-B27 were incubated with the MAb 
F4/326 or with 10 &ml of the purified p58-lg fusion proteins cl8-lg, 
cl42-lg, or the Fc portion of human IgGl (control) for 1 hr at 4% The 
cells were then washed and incubated with fluorescein isothiocyanate 
(FITC) conjugates of either goat anti-human or goat anti-mouse anti- 
bodies (Jackson ImmunoResearch Laboratories) for 30 min at 4°C. 
Fluorescence on a total of 5.000 cells was then analyzed by flow cytom- 
etry on a FACScan (Beckton Dickinson). 
cDNA Cloning and %quenclng 
The screening of a CD3- cDNA library with a probe corresponding to 
thecodingregion ofthep58-c16cDNAhasbaendescribed(Wagtmann 
et al., 1995). Several cDNA clones encoding mofecules with three 
immunoglobulin domains were isolated that could be divided into three 
groups of identical sequences based on partial sequencing of their 5’ 
ends. Representative clones of each group, namely ~1-2, cl-5 and 
cl-l 1, were sequenced completely in both directions using sequenase 
(United States Biochemical). 
Immunity 
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Recombinant Vaccinia Viruwa 
Recombinant vaccinia viruses encoding p56-cl6, p56-cl42, ~1-5, and 
cl-l 1 were generated and purified as described (Earl and Moss, 1966). 
In brief, the full-length p56 cDNA were subcloned as Sall-Nod frag- 
ments into the vector pSC-65 (provided by B. Moss, National Institute 
of Allergy and Infectious Diseases, National Institutes of Health). They 
were then inserted into the WR strain of vaccinia virus by homologous 
recombination. Standard viral plaque assays on CVl cells were used 
lo determine the titer of each of the resulting recombinants. A rewmbi- 
nant vaccinia virus encoding the influenza virus hemagglutinin H3 
molecule has been described (see Gubguen et al., 1994, construcl 
D). The B cell line 721.45 was infected as previously described 
(Gu8guen et al., 1994) with recombinant vaccinia for 1.5 hr at 37OC, 
stalved in methionine-free medium for 1 hr at 37OC, and pulse-labeled 
with 0.1 mCi/ml of [“Sjmethionine. After three washes at 4OC, the cells 
were lysed with 1% Triton X-l 00 and subjected to immunoprecipitation 
and SDS-PAGE on 10.5% gels as described (Wagtmann 81 al.. 1995). 
Radiolabeled proteins were detected by autoradiography. 
Vacclnia Virus Infection of NK Clones 
NK clones were washed three times with infection medium (Iscove’s, 
0.5% bovine serum albumin, 1 x nonessential amino acids, 2 mM 
L-glutamine) at room temperature and resuspended at 0.5 x l@/ml 
in infection medium supplemented with 50 U/ml rll-2 (a gifl from Hoff- 
mann-La Roche. Incorporated). Aliquots (0.5 ml) were given either no 
virus or different doses of recombinant vaccinia virus and incubated 
for 1.5 hr at 37°C on a rotator. After one wash with CTL medium 
(Iscove, 10% fetal calf serum, 2 mM glutamine, 50 U/ml rlL2), cells 
were resuspended in CTL medium and counted. The infected or unin- 
fected control cells were simultaneously plated for standard SICr- 
release killing assays (Malnati et al., 1993) and for antibody staining 
and flow cytometry as described (Wagtmann 81 al., 1995). For each 
NK clone used, a separate titration with each vaccinia virus was per- 
formed. Subsequent infections were with the minimal dose that re- 
sulted in homogeneous infection of the majority of the cells as moni- 
tored by surface staining. 
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